• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

虚拟筛选在药物发现中能走多远?

How far can virtual screening take us in drug discovery?

出版信息

Expert Opin Drug Discov. 2013 Mar;8(3):245-61. doi: 10.1517/17460441.2013.761204. Epub 2013 Jan 21.

DOI:10.1517/17460441.2013.761204
PMID:23330660
Abstract

INTRODUCTION

Virtual screening (VS) has emerged as an important tool in identifying bioactive compounds through computational means, by employing knowledge about the protein target or known bioactive ligands. VS has appeared as an adaptive response to the massive throughput synthesis and screening paradigm as necessity has forced the computational chemistry community to develop tools that screen against any given target and/or property millions or perhaps billions of molecules in short period of time.

AREAS COVERED

This editorial review attempts to catalog most commonly exercised VS methods, available databases for screening, advantages of VS methods along with pitfalls and technical traps with the aim to make VS as one of the most effective tools in drug discovery process. Finally, several case studies are cited where the VS technology has been applied successfully.

EXPERT OPINION

In recent times, many successful examples have been demonstrated in the field of computer-aided VS with the objective of increasing the probability of finding novel hit and lead compounds in terms of cost-effectiveness and commitment in time and material. Despite the inherent limitations, VS is still the best option now available to explore a large chemical space.

摘要

简介

虚拟筛选 (VS) 已成为通过计算手段识别生物活性化合物的重要工具,利用了对蛋白质靶标或已知生物活性配体的了解。VS 作为对大规模高通量合成和筛选范式的适应性反应出现,因为必要性迫使计算化学界开发出能够针对任何给定目标和/或属性筛选数百万甚至数十亿分子的工具,以在短时间内完成筛选。

涵盖领域

本社论综述试图列出最常使用的 VS 方法、可用于筛选的数据库、VS 方法的优点以及陷阱和技术陷阱,旨在使 VS 成为药物发现过程中最有效的工具之一。最后,引用了几个成功应用 VS 技术的案例研究。

专家意见

在最近的一段时间里,计算机辅助 VS 领域已经有了许多成功的例子,目的是在成本效益和时间与材料投入方面提高发现新型命中和先导化合物的可能性。尽管存在固有的局限性,但 VS 仍然是探索大型化学空间的最佳选择。

相似文献

1
How far can virtual screening take us in drug discovery?虚拟筛选在药物发现中能走多远?
Expert Opin Drug Discov. 2013 Mar;8(3):245-61. doi: 10.1517/17460441.2013.761204. Epub 2013 Jan 21.
2
Charting, navigating, and populating natural product chemical space for drug discovery.为药物发现绘制、导航和填充天然产物化学空间。
J Med Chem. 2012 Jul 12;55(13):5989-6001. doi: 10.1021/jm300288g. Epub 2012 May 11.
3
Recognizing pitfalls in virtual screening: a critical review.认识虚拟筛选中的陷阱:批判性评价。
J Chem Inf Model. 2012 Apr 23;52(4):867-81. doi: 10.1021/ci200528d. Epub 2012 Apr 6.
4
Hit finding: towards 'smarter' approaches.靶点发现:迈向“更智能”的方法。
Curr Opin Pharmacol. 2009 Oct;9(5):589-93. doi: 10.1016/j.coph.2009.06.001. Epub 2009 Jul 1.
5
Fragment-based lead discovery on G-protein-coupled receptors.基于片段的 G 蛋白偶联受体的先导化合物发现。
Expert Opin Drug Discov. 2013 Jul;8(7):811-20. doi: 10.1517/17460441.2013.794135. Epub 2013 Apr 29.
6
Recent advances in computer-aided drug design.计算机辅助药物设计的最新进展。
Brief Bioinform. 2009 Sep;10(5):579-91. doi: 10.1093/bib/bbp023. Epub 2009 May 11.
7
The holistic integration of virtual screening in drug discovery.虚拟筛选在药物发现中的整体整合。
Drug Discov Today. 2013 Apr;18(7-8):358-64. doi: 10.1016/j.drudis.2013.01.007. Epub 2013 Jan 20.
8
Novel trends in high-throughput screening.高通量筛选的新趋势。
Curr Opin Pharmacol. 2009 Oct;9(5):580-8. doi: 10.1016/j.coph.2009.08.004. Epub 2009 Sep 21.
9
BEAR, a novel virtual screening methodology for drug discovery.BEAR,一种用于药物发现的新型虚拟筛选方法。
J Biomol Screen. 2011 Jan;16(1):129-33. doi: 10.1177/1087057110388276. Epub 2010 Nov 17.
10
Virtual compound screening in drug discovery.虚拟化合物筛选在药物发现中的应用。
Future Med Chem. 2012 Apr;4(5):593-602. doi: 10.4155/fmc.12.19.

引用本文的文献

1
Virtual screening: hope, hype, and the fine line in between.虚拟筛选:希望、炒作与二者之间的微妙界限。
Expert Opin Drug Discov. 2025 Feb;20(2):145-162. doi: 10.1080/17460441.2025.2458666. Epub 2025 Jan 27.
2
Conformational Space Profiling Enhances Generic Molecular Representation for AI-Powered Ligand-Based Drug Discovery.构象空间分析增强了人工智能驱动的基于配体的药物发现中的通用分子表示。
Adv Sci (Weinh). 2024 Oct;11(40):e2403998. doi: 10.1002/advs.202403998. Epub 2024 Aug 29.
3
A novel heuristic of rigid docking scores positively correlates with full-length nuclear receptor LRH-1 regulation.
一种新型刚性对接评分启发式方法与全长核受体LRH-1调控呈正相关。
Comput Struct Biotechnol J. 2024 Jul 30;23:3065-3080. doi: 10.1016/j.csbj.2024.07.021. eCollection 2024 Dec.
4
Ligand-Based Virtual Screening for Discovery of Indole Derivatives as Potent DNA Gyrase ATPase Inhibitors Active against and Hit Validation by Biological Assays.基于配体的虚拟筛选发现吲哚衍生物作为有效的 DNA 拓扑异构酶 ATP 酶抑制剂,针对 和通过生物测定进行命中验证。
J Chem Inf Model. 2024 Aug 12;64(15):5991-6002. doi: 10.1021/acs.jcim.4c00511. Epub 2024 Jul 12.
5
Challenges in natural product-based drug discovery assisted with -based methods.基于[具体方法]辅助的天然产物药物发现中的挑战。 (原文中“-based methods”处表述不完整,可能影响准确理解)
RSC Adv. 2023 Oct 30;13(45):31578-31594. doi: 10.1039/d3ra06831e. eCollection 2023 Oct 26.
6
Navigating the Chemical Space and Chemical Multiverse of a Unified Latin American Natural Product Database: LANaPDB.探索统一的拉丁美洲天然产物数据库(LANaPDB)的化学空间和化学多元宇宙。
Pharmaceuticals (Basel). 2023 Sep 30;16(10):1388. doi: 10.3390/ph16101388.
7
Virtual Screening Process: A Guide in Modern Drug Designing.虚拟筛选流程:现代药物设计指南。
Methods Mol Biol. 2024;2714:21-31. doi: 10.1007/978-1-0716-3441-7_2.
8
Progress and Impact of Latin American Natural Product Databases.拉丁美洲天然产物数据库的进展与影响。
Biomolecules. 2022 Aug 30;12(9):1202. doi: 10.3390/biom12091202.
9
Chemical named entity recognition in the texts of scientific publications using the naïve Bayes classifier approach.使用朴素贝叶斯分类器方法在科学出版物文本中进行化学命名实体识别。
J Cheminform. 2022 Aug 13;14(1):55. doi: 10.1186/s13321-022-00633-4.
10
Natural Compounds or Their Derivatives against Breast Cancer: A Computational Study.天然化合物或其衍生物防治乳腺癌的计算研究。
Biomed Res Int. 2022 Jul 5;2022:5886269. doi: 10.1155/2022/5886269. eCollection 2022.